Investor Alert

New York Markets Open in:

press release

June 8, 2022, 4:00 p.m. EDT

Alkermes to Participate in the Goldman Sachs Healthcare Conference

Jun 08, 2022 (PRNewswire via COMTEX) -- PR Newswire

DUBLIN, June 8, 2022

DUBLIN, June 8, 2022 /PRNewswire/ -- Alkermes plc /zigman2/quotes/205084517/composite ALKS -3.18% announced today that management will participate in a fireside chat at the Goldman Sachs 43 [rd] Annual Global Healthcare Conference on Wednesday, June 15, 2022 at 2:40 p.m. PT (5:40 p.m. ET/10:40 p.m. BST). The live webcast may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience and oncology. The company has a portfolio of proprietary commercial products focused on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurodegenerative disorders and cancer. Headquartered in Dublin, Ireland, Alkermes has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com .

Alex Braun
Investor Relations
+1 781 296 8493

View original content to download multimedia: https://www.prnewswire.com/news-releases/alkermes-to-participate-in-the-goldman-sachs-healthcare-conference-301563683.html

SOURCE Alkermes plc


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

Copyright (C) 2022 PR Newswire. All rights reserved

US : U.S.: Nasdaq
$ 25.61
-0.84 -3.18%
Volume: 956,106
Aug. 17, 2022 4:00p
P/E Ratio
Dividend Yield
Market Cap
$4.34 billion
Rev. per Employee


Partner Center

Link to MarketWatch's Slice.